Literature DB >> 30068940

PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.

Xisheng Yang1, Shibin Qu1,2, Lin Wang1, Hongtao Zhang1, Zhaoxu Yang1, Jianlin Wang1, Bin Dai1, Kaishan Tao1, Runze Shang1, Zhengcai Liu1, Xiao Li1, Zhuochao Zhang1, Congcong Xia1, Ben Ma1, Wei Liu1, Haimin Li3, Kefeng Dou4.   

Abstract

Nuclear-enriched RNA-binding proteins (RBPs) are mainly involved in transcriptional regulation, which is a critical checkpoint to tune gene diversity and expression levels. We analyzed nuclear RBPs in human HCC tissues and matched normal control tissues. Based on the gene expression levels, PTBP3 was identified as top-ranked in the nuclei of HCC cells. HCC cell lines then were transfected with siRNAs or lentiviral vectors. PTBP3 promoted HCC cell proliferation and metastasis both in vitro and in vivo. RNA immunoprecipitation (RIP), fluorescence in situ hybridization (FISH) and qRT-PCR assays verified that PTBP3 protein recruited abundant lnc-NEAT1 splicing variants (NEAT1_1 and NEAT1_2) and pre-miR-612 (precursor of miR-612) in the nucleus. NEAT1_1, NEAT1_2 and miR-612 expression levels were determined by PTBP3. Correlational analyses revealed that PTBP3 was positively correlated with NEAT1, but it was inversely correlated with miR-612 in HCC. The P53/CCND1 and AKT2/EMT pathways were determined by NEAT1 and miR-612 respectively in HCC. The PTBP3high and NEAT1high/miR-612low patients had a shorter overall survival. Therefore, nuclear-enriched RBP, PTBP3, promotes HCC cell malignant growth and metastasis by regulating the balance of splicing variants (NEAT1_1, NEAT1_2 and miR-612) in HCC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30068940     DOI: 10.1038/s41388-018-0416-8

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

Review 1.  Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability.

Authors:  Maddalen Jimenez; María Arechederra; Matías A Ávila; Carmen Berasain
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-31

2.  Silencing long non-coding RNA NEAT1 enhances the suppression of cell growth, invasion, and apoptosis of bladder cancer cells under cisplatin chemotherapy.

Authors:  Wenchao Zhao; Wenqi Li; Xin Jin; Tianli Niu; Yuanfei Cao; Peng Zhou; Minghua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

3.  Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining.

Authors:  Piyou Ji; Haitao Wang; Yu Cheng; Shaohua Liang
Journal:  J Gastrointest Oncol       Date:  2021-12

4.  Identification of heterogeneous nuclear ribonucleoprotein as a candidate biomarker for diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Youli Du; Xiaoou Ma; Dongxu Wang; Yuguang Wang; Tianyu Zhang; Lianjie Bai; Yunlong Liu; Shaosen Chen
Journal:  J Gastrointest Oncol       Date:  2021-10

Review 5.  RNA splicing: a dual-edged sword for hepatocellular carcinoma.

Authors:  Anjali Kashyap; Greesham Tripathi; Avantika Tripathi; Rashmi Rao; Manju Kashyap; Anjali Bhat; Deepak Kumar; Anjali Rajhans; Pravindra Kumar; Darshan Shimoga Chandrashekar; Riaz Mahmood; Amjad Husain; Hatem Zayed; Alok Chandra Bharti; Manoj Kumar Kashyap
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

6.  LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer by Targeting ZEB1 via miR-448.

Authors:  Hanquan Wu; Dengwen Dong; Jiwei Wang; Shiwen Yin; Yuanxiang Gong; Chao Yang; Yihan Bai; Junyi Wang; Yanhong Du
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 7.  One locus with two roles: microRNA-independent functions of microRNA-host-gene locus-encoded long noncoding RNAs.

Authors:  Qinyu Sun; You Jin Song; Kannanganattu V Prasanth
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-09-17       Impact factor: 9.957

8.  FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via MDM2-dependent p53 signaling in GSCs.

Authors:  Yang Jiang; Zhenlin Wang; Chenting Ying; Jiangfeng Hu; Tao Zeng; Liang Gao
Journal:  Oncogene       Date:  2021-05-20       Impact factor: 9.867

9.  LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.

Authors:  Yiran Liang; Xiaojin Song; Yaming Li; Bing Chen; Wenjing Zhao; Lijuan Wang; Hanwen Zhang; Ying Liu; Dianwen Han; Ning Zhang; Tingting Ma; Yajie Wang; Fangzhou Ye; Dan Luo; Xiaoyan Li; Qifeng Yang
Journal:  Mol Cancer       Date:  2020-05-08       Impact factor: 27.401

Review 10.  RNA-binding proteins in tumor progression.

Authors:  Hai Qin; Haiwei Ni; Yichen Liu; Yaqin Yuan; Tao Xi; Xiaoman Li; Lufeng Zheng
Journal:  J Hematol Oncol       Date:  2020-07-11       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.